Open an Account
search icon
4
NOTIFICATIONS
Best Algo trading app in India
Bigul

UNICHEM LABORATORIES LTD. - 506690 - Board Meeting Intimation for Board Meeting Intimation For To Approve Audited Results (Standalone And Consolidated ) For The Year Ended March 31, 202 And Recommendation Of Final Dividend, If Any.

 UNICHEM LABORATORIES LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 27/05/2022 ,inter alia, to consider and approve Audited Results (Standalone And Consolidated ) For The Year Ended March 31, 202 And Recommendation Of Final Dividend, If Any.
19-05-2022
Bigul

UNICHEM LABORATORIES LTD. - 506690 - Announcement under Regulation 30 (LODR)-Newspaper Publication

 Submission of Advertisement Published in Newspapers regarding Notice for transfer of Equity Shares and Unclaimed Dividend to the Investor Education and Protection Fund (IEPF) Account.
17-05-2022
Bigul

UNICHEM LABORATORIES LTD. - 506690 - Liquidation Of Strategic Investment Made By The Company .

 Liquidation of Strategic Investment made by the Company .
10-05-2022
Bigul

UNICHEM LABORATORIES LTD. - 506690 - Format of the Initial Disclosure to be made by an entity identified as a Large Corporate : Annexure A

 Format of Initial Disclosure to be made by an entity identified as a Large Corporate. Sr. No. Particulars Details 1Name of CompayUNICHEM LABORATORIES LTD. 2CINL99999MH1962PLC012451 3 Outstanding borrowing of company as on 31st March / 31st December, as applicable (in Rs cr) 115.00 4Highest Credit Rating during the previous FY A- 4aName of the Credit Rating Agency issuing the Credit Rating mentioned in (4)ICRA LIMITED 5Name of Stock Exchange# in which the fine shall be paid, in case of shortfall in the required borrowing under the frameworkBSE We confirm that we are a Large Corporate as per the applicability criteria given under the SEBI circular SEBI/HO/DDHS/CIR/P/2018/144 dated November 26, 2018. No Name of the Company Secretary: Pradeep Bhandari Designation: Head Legal and CS EmailId: pradeep.bhandari@unichemlabs.com Name of the Chief Financial Officer: Sandip Ghume Designation: Deputy CFO EmailId: sandip.ghume@unichemlabs.com Date: 28/04/2022 Note: In terms para of 3.2(ii) of the circular, beginning F.Y 2022, in the event of shortfall in the mandatory borrowing through debt securities, a fine of 0.2% of the shortfall shall be levied by Stock Exchanges at the end of the two-year block period. Therefore, an entity identified as LC shall provide, in its initial disclosure for a financial year, the name of Stock Exchange to which it would pay the fine in case of shortfall in the mandatory borrowing through debt markets.
28-04-2022
Bigul

UNICHEM LABORATORIES LTD. - 506690 - CERTIFICATE UNDER REGULATION 40(9) OF THE SEBI (LODR) REGULATIONS, 2015 FOR THE YEAR ENDED 31.03.2022

 COMPLIANCE CERTIFICATE UNDER REGULATION 40(9) OF THE SEBI (LODR) REGULATIONS, 2015 FOR THE YEAR ENDED 31.03.2022
14-04-2022
Bigul

UNICHEM LABORATORIES LTD. - 506690 - Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018

 Compliance Certificate under regulation 74[5) of the SEBI (Depositories and Participants) Regulations, 2018 for the quarter ended March 31, 2022
11-04-2022
Bigul

UNICHEM LABORATORIES LTD. - 506690 - Compliance Certificate For The Period April 1, 2021 To March 31, 2022 (Both Days Inclusive)

 As per the requirement of Regulation 7 (3) of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we hereby confirm that activities in relation to both physical and electronic share transfer facility are maintained during the period April 1, 2021 to March 31, 2022 (both days inclusive) by the Company's Registrar and Share Transfer Agent, viz., Link Intime India Private Limited, which is registered as Registrar & Share Transfer Agent in Category-I with the Securities and Exchange Board of India vide Registration Number: INR000004058.
11-04-2022
Bigul

UNICHEM LABORATORIES LTD. - 506690 - Statement Of Investor Complaints For The Quarter Ended March 2022

 No.of Investor complaints pending at the beginning of the quarter No.of Investor complaints received during the quarter No.of Investor complaints disposed of during the quarter No.of Investor complaints unresolved at the end of the quarter 0000 Name of the Signatory :- Pradeep BhandariDesignation :- Company Secretary and Compliance Officer
11-04-2022
Bigul

UNICHEM LABORATORIES LTD. - 506690 - Closure of Trading Window

 Notice of trading window close.
31-03-2022

Unichem Laboratories gets USFDA approval for generic Nebivolol tablets

 Unichem Laboratories on Wednesday said it has received approval from the US health regulator to market its generic version of Nebivolol tablets indicated for the treatment of hypertension
16-03-2022
Next Page
Close

Let's Open Free Demat Account